atai life sciences advances vls-01 for treatment-resistant depression
Published 5 months ago • 6.7K plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
8:17
atai life sciences reveals positive clinical trial results and discusses fda ruling on mdma
-
7:07
atai life sciences outlines key milestones in psychedelic therapy for depression in 2023 and 2024
-
11:56
atai life sciences 'bringing innovation to mental healthcare and treatment addiction'
-
5:29
atai life sciences co-ceo says initial results from ele-101 show promise in treating depression
-
26:21
florian brand (atai life sciences): psychedelics – the new psychiatric frontier | slush 2021
-
3:59
atai life sciences founder on using psychedelics to treat mental illness
-
33:00
florian brand talks of innovation in mental healthcare to tackle depression, anxiety and addiction
-
34:44
what atai life sciences 9 clinical trials means for investors
-
2:11
artiq explainer video
-
48:00
psychedelics for depression: the promise, risks, & costs - srinivas rao (mapping the mind 2019)
-
3:09
psilocybin found to rapidly improve depressive symptoms in patients
-
1:41
life-changing drug fights depression in hours
-
3:55
the cycle of basic science and clinical trials – cvr onlife
-
15:08
athersys
-
8:47
available attr selective stabilizers
-
15:12
viacyte
-
11:35
technology and the converging paths of mental health – dr arshya vahabzadeh
-
4:17
at last, hope for als patients?
-
2:53
easd 2018 toshinari takamura